Please contact us for more information or to learn if you are eligible to participate.
This protocol will determine the percentage of newborns with high DB/CB levels at participating pediatric hospitals. It will also determine the percentage of those that still have high levels at the two-week newborn follow-up.
Principal Investigator | Sanjiv Harpavat, MD |
Type of Trial | Retrospective |